🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our
Cookie Policy
.
Accept All
Necessary Only
Evidence-based GLP-1 & peptide discussion since 2023
FAQ
|
Rules
|
Members
GL
The GLP
Lounge
Peptide & GLP-1 Community
Log In
Register
Forums
New
Trending
Members
Wiki
Forums
›
Cardiovascular Outcomes
Cardiovascular Outcomes
87 threads · 1.2K posts
D
Study
SELECT trial: 20% MACE reduction — mechanistic deep dive
Dr.CardioMD
· Yesterday at 11:34 PM
7
Replies
63
Views
D
Dr.CardioMD
Yesterday at 11:34 PM
D
Study
Semaglutide cardiovascular benefit independent of weight loss
Dr.CardioMD
· Yesterday at 9:52 PM
11
Replies
302
Views
D
Dr.CardioMD
Yesterday at 9:52 PM
D
Study
STEP-HFpEF: semaglutide in heart failure with preserved EF
Dr.CardioMD
· Yesterday at 5:10 PM
15
Replies
378
Views
D
Dr.CardioMD
Yesterday at 5:10 PM
D
Study
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data
Dr.MetabolicMD
· Yesterday at 9:29 AM
18
Replies
410
Views
D
Dr.MetabolicMD
Yesterday at 9:29 AM
LA
New
Lp(a) on GLP-1 agonists — any impact on this risk factor?
LipidDoc_ATL
· Sunday at 10:49 PM
8
Replies
202
Views
LA
LipidDoc_ATL
Sunday at 10:49 PM
D
Study
Blood pressure reduction mechanisms on GLP-1 — natriuresis
Dr.RenalNash
· Sunday at 9:10 AM
18
Replies
335
Views
D
Dr.RenalNash
Sunday at 9:10 AM
LA
Study
ApoB reduction on tirzepatide — SURPASS lipid substudies
LipidDoc_ATL
· Saturday at 4:31 PM
13
Replies
243
Views
LA
LipidDoc_ATL
Saturday at 4:31 PM
D
Study
Anti-thrombotic properties of GLP-1 receptor activation
Dr.CardioMD
· Friday at 8:54 PM
17
Replies
252
Views
D
Dr.CardioMD
Friday at 8:54 PM
HD
Study
SELECT cost-effectiveness — NNT analysis for MACE prevention
HealthEcon_DC
· Thursday at 10:17 PM
13
Replies
458
Views
HD
HealthEcon_DC
Thursday at 10:17 PM
D
New
Heart rate increase on GLP-1 — clinical significance assessment
Dr.CardioMD
· Wednesday at 8:41 PM
2
Replies
194
Views
D
Dr.CardioMD
Wednesday at 8:41 PM
D
Study
SOUL trial preliminary data — semaglutide in T2DM cardiovascular outcomes
Dr.CardioMD
· Tuesday at 4:06 PM
20
Replies
546
Views
D
Dr.CardioMD
Tuesday at 4:06 PM
D
Study
GLP-1 and atrial fibrillation risk — emerging signal or noise?
Dr.RaviCardio
· Jun 1, 2026
15
Replies
423
Views
D
Dr.RaviCardio
Jun 1, 2026
D
Study
Echocardiographic changes on GLP-1 — LV mass and diastolic function
Dr.CardioMD
· May 30, 2026
20
Replies
460
Views
D
Dr.CardioMD
May 30, 2026
D
Study
Coronary artery calcium score changes on GLP-1 — 2-year follow-up
Dr.RaviCardio
· May 29, 2026
14
Replies
356
Views
D
Dr.RaviCardio
May 29, 2026
D
New
GLP-1 and peripheral arterial disease — claudication improvement data
Dr.CardioMD
· May 27, 2026
8
Replies
449
Views
D
Dr.CardioMD
May 27, 2026
1
2
3
…
8
Users browsing this forum:
Admin
,
Dr.Martinez
,
mike_mod
,
sarah.morrison
and 13 guests
The GLP Lounge Weekly Digest
Top threads, new research, and vendor alerts every Friday.
Subscribe
Forums
New
Trending
Members
Account
Log In
×
Username or Email
Password
Remember me
Forgot password?
Log In
No account?
Register
Create Account
×
Username
*
3-20 characters, letters/numbers/underscores
Email
*
Password
*
Confirm
*
Date of Birth
*
You must be 18 or older to register
I agree to the
Terms of Service
and
Privacy Policy
, and confirm I am 18+.
Create Account
Already have an account?
Log in
Activate Account
×
Activation email sent!
We sent a 6-digit code to
. Check your inbox (and spam folder).
Activation Code
Did not receive it?
Resend code
Activate Account